Welcome to our dedicated page for ALLSTATE SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
Allstate Corporation director Margaret M. Keane reported a routine equity compensation transaction. On 01/01/2026, she acquired 162 shares of Allstate common stock at $208.15 per share through an election to receive stock instead of cash fees under Allstate’s 2017 Equity Compensation Plan for Non-Employee Directors. After this and prior activity, she beneficially owns 16,514.718 shares of Allstate common stock. This balance includes 76.041 shares accumulated between July 3, 2025 and January 2, 2026 through a dividend reinvestment program.
The Allstate Corporation director reports routine equity compensation activity. On 01/01/2026, the reporting person acquired 198 shares of Allstate common stock at $208.15 per share, electing to receive stock instead of cash fees under The Allstate Corporation 2017 Equity Compensation Plan for Non-Employee Directors. After this transaction, the director directly owned 5,653.379 Allstate common shares, which also include 48.254 shares accumulated through dividend reinvestment between July 3, 2025 and January 2, 2026.
The filing also shows 7,703.604 common share units held under The Allstate Corporation Amended and Restated Deferred Compensation Plan for Non-Employee Directors, representing deferred director fees and dividend equivalents. For the period from October 2, 2025 through January 2, 2026, the director received 37.612 additional common share units from dividends credited under this deferred compensation arrangement.
A holder of common stock in issuer ALL, identified as the Thomas J. Wilson Revocable Trust, has filed to sell 100,842 shares of common stock on the NYSE through Goldman Sachs & Co. LLC. The planned sale has an aggregate market value of $20,553,616.44, compared with 261,681,708 shares of common stock outstanding.
The shares to be sold were originally acquired from the issuer on 02/21/2012 as compensation through performance awards. Over the past three months, the same trust has completed multiple sales of 16,807 shares of common stock on several dates, each generating multimillion-dollar gross proceeds, indicating an ongoing selling program under Rule 144.
Allstate Corporation Chairman, President & CEO Thomas J. Wilson reported several internal transfers of Allstate common stock involving his personal trusts and direct ownership. On December 19, 2025, 61,308 shares previously held by the Thomas J. Wilson 2023-B GRAT Trust were distributed to his direct ownership, and 50,134 shares from the same 2023-B GRAT were transferred to the Thomas J. Wilson 2020 GRAT Remainder Trust at a reported price of $0 per share.
The filing also notes a distribution of 33,421 shares from the Thomas J. Wilson 2024-C GRAT Trust to direct ownership on the same date. After receiving these shares, he contributed a total of 94,729 shares to the Thomas J. Wilson 2025-E GRAT Trust. Following these moves, he continues to hold Allstate stock directly and indirectly through multiple GRATs and a 401(k) plan.
The Allstate Corporation furnished a Regulation FD report to provide access to its November 2025 monthly release on estimated catastrophe losses and policies in force.
The company states that this release is posted on allstateinvestors.com and is attached as Exhibit 99, a press release dated December 18, 2025 that is furnished, not filed.
The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open-market sales of Allstate common stock and related option movements. On December 15, 2025, he sold Allstate shares in several transactions at weighted-average prices of $208.3456, $209.3955, $210.3659 and $210.9611 per share under a Rule 10b5-1 trading plan adopted on June 27, 2025.
After these sales, he directly owned 128,005.491 Allstate shares, with additional indirect holdings through multiple GRATs, a 401(k) plan and trusts. The filing also lists employee stock options with exercise prices of $122.64, $137.10 and $159.17 per share, some of which were transferred on December 12, 2025 to TJW Options LLC series entities, while other option tranches remain directly held and vest in increments through 2027.
The Allstate Corporation’s chairman, president and CEO Thomas J. Wilson reported open‑market sales of company stock. On 12/01/2025, he sold 12,603 shares of Allstate common stock at a weighted average price of $212.4797, with individual sale prices ranging from $212.040 to $213.025. The same day, he sold another 4,204 shares at a weighted average price of $213.2706, with trades between $213.060 and $213.530. These transactions were carried out under a Rule 10b5‑1 trading plan adopted on June 27, 2025. After these sales, Wilson directly holds 144,812.491 shares of Allstate common stock and also reports additional indirect ownership through several GRATs, a 401(k) plan, and a remainder trust.
The Allstate Corporation executive reports option exercises and share sales. President, Enterprise Solutions Suren Gupta exercised employee stock options to buy 750 shares of Allstate common stock at $62.32 per share on 11/26/2025 and 3,786 shares at the same exercise price on 11/28/2025. On each date, he sold the same number of shares in open-market transactions at weighted average prices of $215.0083 and $215.1334, respectively, under a Rule 10b5-1(c) trading plan adopted on June 9, 2025.
After these transactions, Gupta directly beneficially owns 100,646 Allstate shares, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC. He also holds 19,593 remaining employee stock options with a $62.32 exercise price expiring on 02/11/2026.
A holder has filed a Form 144 notice to potentially sell 33,614 shares of common stock through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of $7,058,940. The issuer has 261,681,708 shares outstanding, providing context for the size of this planned sale.
The shares to be sold were originally acquired from the issuer as compensation via performance awards on February 22, 2018 (30,113 shares) and February 21, 2012 (3,501 shares), with payment in the form of compensation rather than cash. The seller, identified as the Thomas J. Wilson Revocable Trust dtd 03/13/15, has also sold four prior 16,807‑share blocks of common stock in the past three months, each generating multi‑million‑dollar gross proceeds, and represents that it is not aware of undisclosed material adverse information about the issuer.
Allstate insider plans additional stock sale under Rule 144
A holder of Allstate common stock has filed a Form 144 indicating an intention to sell 3,786 shares through Fidelity Brokerage Services on the NYSE. The planned sale, dated 11/28/2025, relates to shares acquired the same day via an option granted on 02/11/2016 and paid for in cash. The filing notes 261,681,708 Allstate common shares outstanding, giving context for the size of this transaction.
Over the prior three months, the same seller, Suren K. Gupta, reported multiple open‑market sales of Allstate common stock, including 1,400 shares on 11/14/2025, 400 shares on 11/17/2025, 21,871 shares on 11/21/2025, 600 shares on 11/24/2025, and 750 shares on 11/26/2025, with disclosed gross proceeds for each trade. The signer represents that they are not aware of undisclosed material adverse information about Allstate when making or planning these sales.